Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 174, Issue 6, Pages 887-898
Publisher
Wiley
Online
2016-06-07
DOI
10.1111/bjh.14140
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study
- (2015) J. Donadieu et al. BLOOD
- Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning
- (2015) Paul A. Veys et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cell(s) of Origin of Langerhans Cell Histiocytosis
- (2015) Matthew Collin et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Ethnicity, race, and socioeconomic status influence incidence of langerhans cell histiocytosis
- (2015) Karina Braga Ribeiro et al. PEDIATRIC BLOOD & CANCER
- Vemurafenib Use in an Infant for High-Risk Langerhans Cell Histiocytosis
- (2015) Sébastien Héritier et al. JAMA Oncology
- BRAF-V600Eexpression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
- (2014) Marie-Luise Berres et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis
- (2013) H. Gadner et al. BLOOD
- Medical management of langerhans cell histiocytosis from diagnosis to treatment
- (2012) Jean Donadieu et al. EXPERT OPINION ON PHARMACOTHERAPY
- Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years
- (2012) Riccardo Haupt et al. PEDIATRIC BLOOD & CANCER
- Recurrent BRAF mutations in Langerhans cell histiocytosis
- (2010) G. Badalian-Very et al. BLOOD
- Central Nervous System Disease in Langerhans Cell Histiocytosis
- (2010) Nicole Grois et al. JOURNAL OF PEDIATRICS
- Improved outcome of refractory Langerhans cell histiocytosis in children with hematopoietic stem cell transplantation in Japan
- (2009) K Kudo et al. BONE MARROW TRANSPLANTATION
- 2′-chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the histiocyte society
- (2009) Sheila Weitzman et al. PEDIATRIC BLOOD & CANCER
- Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland
- (2008) J A Salotti et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Reactivations in Multisystem Langerhans Cell Histiocytosis: Data of the International LCH Registry
- (2008) Milen Minkov et al. JOURNAL OF PEDIATRICS
- Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000–2004
- (2008) Aurélie Guyot-Goubin et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now